`
`United States Court of Appeals
`for the Federal Circuit
`______________________
`
`MODERNATX, INC., FKA MODERNA
`THERAPEUTICS, INC.,
`Appellant
`
`v.
`
`ARBUTUS BIOPHARMA CORPORATION, FKA
`PROTIVA BIOTHERAPEUTICS, INC.,
`Cross-Appellant
`
`
`
`
`
`
`
`ANDREW HIRSHFELD, PERFORMING THE
`FUNCTIONS AND DUTIES OF THE UNDER
`SECRETARY OF COMMERCE FOR
`INTELLECTUAL PROPERTY AND DIRECTOR
`OF THE UNITED STATES PATENT AND
`TRADEMARK OFFICE,
`Intervenor
`______________________
`2020-1184, 2020-1186
`______________________
`Appeals from the United States Patent and Trademark
`Office, Patent Trial and Appeal Board in No. IPR2018-
`00739.
`
`______________________
`
`MANDATE
`______________________
`In accordance with the judgment of this Court, entered
`December 1, 2021, and pursuant to Rule 41 of the Federal
`
`
`
`Case: 20-1184 Document: 137 Page: 2 Filed: 01/25/2022
`
`Rules of Appellate Procedure, the formal mandate is
`hereby issued.
`
`
`FOR THE COURT
`
`
`/s/ Peter R. Marksteiner
`Peter R. Marksteiner
`Clerk of Court
`
`
`
`
`
`January 25, 2022
`
`Date
`
`
`
`
`
`
`
`